Hyaluronan signaling and turnover
Author(s)
Bibliographic Information
Hyaluronan signaling and turnover
(Advances in cancer research / edited by George Klein and Sidney Weinhouse, v. 123)
Academic Press is an imprint of Elsevier, 2014
Available at 9 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographical references and index
Description and Table of Contents
Description
Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. Here, once again, outstanding and original reviews are presented on a variety of topics. This volume covers hyaluronan signaling and turnover.
Table of Contents
1.Emerging Roles for Hyaluronidase in Cancer Metastasis and Therapy2.Targeting Hyaluronic Acid Family for Cancer Chemoprevention & Therapy3.Aberrant Post-Transcriptional Processing of Hyaluronan Synthase 1 in Malignant Transformation and Tumor Progression 4.Hyaluronan Synthases Post-Translational Regulation in Cancer5.Hyaluronon-Coated Extracellular Vesicles - A Novel Link Between Hyaluronan and Cancer6.Hyaluronan in the Healthy and Malignant Hematopoietic Microenvironment7.Hyaluronan Regulation of Endothelial Barrier Function in Cancer8.HAS2 and CD44 in Breast Tumorigenesis9.CD44 is a Multidomain Signaling Platform that Integrates Extracellular Matrix Cues with Growth Factor and Cytokine Signals10.Hyaluronan-CD44 Interaction Promotes Oncogenic Signaling, MicroRNA Functions, Chemoresistance and Radiation Resistance in Cancer Stem Cells Leading to Tumor Progression11.Advances and Advantages of Nanomedicine in the Pharmacological Targeting of Hyaluronan-CD44 Interactions and Signaling in Cancer12.Hyaluronan / RHAMM Interactions in Mesenchymal Tumor Pathogenesis: Role of Growth Factors13.CD147: Regulator of Hyaluronan Signaling in Invasiveness and Chemoresistance
by "Nielsen BookData"